Almstead Neil Gregory's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Jun 26, 2026
- Accession no.
- 0001578850-26-000017
- Filed
- Jun 26, 2026
- Trade date
- Jun 24-25, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 12 non-derivative transactions and 5 derivative transactions. Open-market sales total $2.25M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Almstead Neil GregoryCIK 0001578850 | Officer (CHIEF TECHNICAL OPS OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Common Stock | MOption exerciseAcquired | +401 | $38.10 | +$15,278.1 | 60,538 | Direct | |
| Jun 24, 2026 | Common Stock | SSaleDisposed | −401 | $85.01F2 | −$34,089.01 | 60,137 | Direct | |
| Jun 24, 2026 | Common Stock | MOption exerciseAcquired | +4,922 | $38.10 | +$187,528.2 | 65,059 | Direct | |
| Jun 24, 2026 | Common Stock | SSaleDisposed | −4,922 | $85.03F3 | −$418,517.66 | 60,137 | Direct | |
| Jun 25, 2026 | Common Stock | MOption exerciseAcquired | +1,001 | $38.10 | +$38,138.1 | 61,138 | Direct | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −582 | $85.24F4 | −$49,609.68 | 60,556 | Direct | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −419 | $86.39F5 | −$36,197.41 | 60,137 | Direct | |
| Jun 25, 2026 | Common Stock | MOption exerciseAcquired | +19,859 | $38.10 | +$756,627.9 | 79,996 | Direct | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −8,522 | $85.26F6 | −$726,585.72 | 71,474 | Direct | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −11,337 | $86.51F7 | −$980,763.87 | 60,137 | Direct | |
| Jun 25, 2026 | Common Stock | MOption exerciseAcquired | +100 | $39.42 | +$3,942 | 60,237 | Direct | |
| Jun 25, 2026 | Common Stock | SSaleDisposed | −100 | $87.00 | −$8,700 | 60,137 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Common Stock | MOption exerciseDisposed | −401 | $0.00 | $0 | 53,599 | Direct | |
| Jun 24, 2026 | Common Stock | MOption exerciseDisposed | −4,922 | $0.00 | $0 | 48,677 | Direct | |
| Jun 25, 2026 | Common Stock | MOption exerciseDisposed | −1,001 | $0.00 | $0 | 47,676 | Direct | |
| Jun 25, 2026 | Common Stock | MOption exerciseDisposed | −19,859 | $0.00 | $0 | 27,817 | Direct | |
| Jun 25, 2026 | Common Stock | MOption exerciseDisposed | −100 | $0.00 | $0 | 36,150 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.03 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.14 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.84 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $86.23 to $86.59 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.98 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $86.02 to $86.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.